Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEAL-LAST: IV Albumin for Cognitive Improvement in Hepatic Encephalopathy
NCT06052176Phase 2Active, not recruiting
- Sponsor
- Richmond VA Medical Center
- Start
- Nov 2023
- Primary completion
- Oct 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of albumin (human) in hepatic encephalopathy (HE), sponsored by Richmond VA Medical Center. Started Nov 2023; status: active, not recruiting.
02
Drugs
albumin (human)
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT06052176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06052176.